n 82-year-old Caucasian man presented to his primary care physician with a 9.1 kg unintentional weight loss, decreased appetite and new-onset difficulty in voiding. Five years previously, the patient underwent suprapubic prostatectomy for benign prostatic hypertrophy, with no malignancy on transrectal ultrasound biopsies. Initial laboratory results showed abnormal levels of prostate-specific antigen (PSA) 1.57 µg/L (normal less than 0.065 µg/L), aspartate transaminase 100 U/L (normal range 5 U/L to 43 U/L), alanine transaminase 82 U/L (normal 10 U/L to 58 U/L), alkaline phosphatase 577 U/L (normal range 40 U/L to 129 U/L), total bilirubin 29.07 µmol/L (normal less than 20.52 µmol/L) and direct bilirubin 10.06 µmol/L (normal 6.84 µmol/L). The patient's PSA level three years previously was 0.01 µg/L. An abdominal ultrasound showed normal liver parenchyma, intrahepatic biliary ductal dilation with a normal common bile duct (6 mm in diameter) without any stones or sludge within the biliary tree, a solid peripancreatic mass (1.6 cm × 2.3 cm × 1.3 cm in size) and ascites. A subsequent computed tomography (CT) scan showed extensive peripancreatic and retroperitoneal adenopathy (3.4 cm in the greatest cross-sectional diameter), a dilated intrahepatic biliary tree and ascites. A transrectal prostate ultrasound and biopsy revealed a prostate adenocarcinoma (Gleason score of 4+5 out of 9) with perineural involvement but no lymphatic, vascular or extraprostatic invasion. A bone scan revealed multiple, small, focal osteoblastic lesions consistent with metastatic disease. An upper endoscopic ultrasound ([EUS] Olympus GF-UM160 and GF-UC140P, Olympus America Inc, USA) revealed eight hypoechoic, heterogeneous, oval and roundshaped lymph nodes (gastrohepatic, periduodenal, peripancreatic and celiac) ( Figure 1 ). The size of the lymph nodes ranged from 15 mm to 30 mm. EUS-guided fine-needle aspiration (FNA) (22 gauge Echotip ultra-endoscopic ultrasound needle, Wilson-Cook Medical Inc, USA) was performed (total of six passes) on the perigastric and celiac lymph nodes. Five millilitres of straw-coloured ascitic fluid was obtained for cytological examination by EUS-guided transgastric puncture. Although intrahepatic biliary dilation was noted, the diameter of the common bile duct (6 mm) was normal. The aspirate and cell block preparations from the lymph nodes showed metastatic adenocarcinomas that were positive for PSA and prostatespecific acid phosphatase, consistent with metastatic prostate adenocarcinoma ( Figure 2 ). Rare aggregates of atypical cells with similar features were present within the ascites specimen. 
DiSCuSSion
The role of EUS is well-established in gastrointestinal, pancreatobiliary, and lung cancer diagnosis and staging (1) . Until the introduction of EUS-FNA, only lymph node echofeatures (ie, size greater than 1 cm), echopoor appearance, distinct margins and round shape were used to predict malignant involvement of a lymph node (2) . The accuracy of predicting malignant involvement of a lymph node is 80% when all four endosonographic criteria are present in a lymph node; however, only 25% of malignant lymph nodes have all four criteria (3). FNA allows for cytological evaluation of a lymph node. EUS-FNA has been found to be superior to lymph node echofeatures alone (4) .
In the United States, adenocarcinoma of the prostate is the most common cause of cancer among men and the second most common cause of cancer mortality (5) . Prostate cancer metastasizes hematogenously and/or lymphogeneously (6) . With the measurement of PSA levels and the evaluation of asymptomatic men for prostate cancer, the incidence of lymph node metastasis has decreased from 40% to 10% (7) . Prostate cancer usually metastasizes to regional lymph nodes. Despite the declining incidence of lymph node metastasis, the number of patients with positive lymph nodes is still significant.
The anatomical proximity of the prostate gland to the rectum allows for the use of EUS for locoregional staging of prostate cancer (8) . EUS and EUS-FNA have rarely been used to detect distant prostate cancer metastases, with only a single report of EUS-FNA of mediastinal lymph nodes (9) . To our knowledge, we describe the first use of EUS-FNA to detect metastatic prostate cancer from celiac and perigastric lymphadenopathy. Celiac lymph nodes, which are located within 2 cm of the origin of the celiac trunk, may be involved with malignant (esophageal, pancreatobiliary, lung cancer and lymphoma) as well as benign diseases (pancreatitis, infections, autoimmune hepatitis and sarcoidosis). Cytology with immunohistochemical staining of FNA samples for tumour markers allowed for the correct diagnosis in the present, unusual case of metastatic prostate cancer. We recommend routine sampling of abnormal-appearing lymph nodes as well as immunohistochemical staining to reach the correct diagnosis.
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